Dr. Reddy’s Schedules Nuvama Investor Conference Meetings in Mumbai on February 9, 2026
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Dr Reddy’s Laboratories ( (RDY) ) just unveiled an announcement.
On February 2, 2026, Dr. Reddy’s Laboratories announced that its management will participate in an investor conference organized by Nuvama in Mumbai on February 9, 2026. The engagement, scheduled as an in-person group meeting running from 09:00 to 17:00 IST, is targeted at analysts and institutional investors, reinforcing the company’s ongoing investor-relations outreach and transparency with capital markets, although the company cautioned that the schedule could change due to exigencies for either investors or the company.
The most recent analyst rating on (RDY) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Dr Reddy’s Laboratories stock, see the RDY Stock Forecast page.
Spark’s Take on RDY Stock
According to Spark, TipRanks’ AI Analyst, RDY is a Outperform.
The score is driven primarily by strong fundamentals (profitability, growth, and low leverage), tempered by weaker cash-flow conversion. Earnings-call takeaways are moderately positive due to pipeline progress and strong liquidity, but near-term margins and regulatory delays add risk. Technicals are neutral-to-soft and valuation is reasonable with a low dividend yield.
To see Spark’s full report on RDY stock, click here.
More about Dr Reddy’s Laboratories
Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company headquartered in Hyderabad, Telangana. It develops, manufactures and markets a broad portfolio of generic medicines, active pharmaceutical ingredients and proprietary products, with a strong presence in regulated markets including the United States and Europe as well as in India and other emerging markets. The company’s shares are listed in India on the NSE and BSE and in the United States on the New York Stock Exchange, underscoring its focus on global investors and institutional stakeholders.
Average Trading Volume: 1,258,653
Technical Sentiment Signal: Hold
Current Market Cap: $11.05B
For an in-depth examination of RDY stock, go to TipRanks’ Overview page.
